NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: 2 out of 5

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

Results 1 - 20 of 30 : 1 2 Next »

Recs

0
Member Avatar stocklade (33.29) Submitted: 1/25/2013 11:59:19 PM : Outperform Start Price: $11.75 NXTM Score: -21.89

Great way of treating renal diseases, Can 't understand why they haven 't Done better. ? Doctor owned dialysis centers

Recs

0
Member Avatar halley12 (57.67) Submitted: 10/9/2012 12:46:29 AM : Outperform Start Price: $12.86 NXTM Score: -35.92

New technology.

Recs

0
Member Avatar iksnamyzs (79.80) Submitted: 10/7/2012 12:56:39 PM : Outperform Start Price: $13.29 NXTM Score: -39.13

buy on dip

Recs

0
Member Avatar WWIBD2012 (39.33) Submitted: 9/26/2012 9:08:35 AM : Outperform Start Price: $12.67 NXTM Score: -35.73

World Wide Invest Better Day 2012 pick, made by Charly Travers, Brenton Flynn, and David Williamson.

Recs

0
Member Avatar snow8880 (< 20) Submitted: 9/14/2012 10:48:11 AM : Outperform Start Price: $13.51 NXTM Score: -38.98

As the baby boomer approach the age that kidneys fail, they will be looking for a convenient way to dialyze. They will not want to spend 3 days in-center.
NXTM just received approval for their home dialysis system from UHC and Aetna. They have appealed to Medicarem (2013 proposed rule) to increase funding for Home HD which has proven to be less costly with a decreased risk of mortality and increased opportunity for transplant. No brainer!

Recs

0
Member Avatar Lcrazylegs84 (< 20) Submitted: 10/1/2011 12:49:34 AM : Outperform Start Price: $20.59 NXTM Score: -114.70

going up

Recs

0
Member Avatar TheRadical (< 20) Submitted: 6/23/2011 4:40:39 PM : Outperform Start Price: $19.96 NXTM Score: -90.74

people have seemed to forget about the potential of this company. While NXTM got of to a hot start initially, the stock has been trending downwards. I'm betting that a couple good earnings reports send NXTM through the roof.

Recs

0
Member Avatar Jamanji (76.40) Submitted: 6/18/2011 9:49:37 AM : Outperform Start Price: $19.23 NXTM Score: -90.29

2011 Forbes Special Edition

Recs

0
Member Avatar Calinvestments (96.59) Submitted: 3/19/2011 8:16:09 PM : Outperform Start Price: $20.20 NXTM Score: -90.22

Having to frequently go to the hospital for dialysis is a huge hassle for patients with kidney problems. I expect the demand for NXTM's "at home" dialysis" machine to continue to grow.

Recs

0
Member Avatar 707oxford (< 20) Submitted: 3/19/2011 8:11:28 PM : Outperform Start Price: $20.20 NXTM Score: -90.22

Having to go to the hospital for dialysis frequently is a huge hassle for kidney patients. NXTM's new machine to "do it yourself" from home should sell very well.

-Caligiuri

Recs

0
Member Avatar hoperalot1 (< 20) Submitted: 9/20/2010 5:58:08 PM : Outperform Start Price: $17.52 NXTM Score: -100.71

Great need for product
Excellent management
A company waiting for a buy out?
20+target

Recs

0
Member Avatar TMFBreakerJava (99.52) Submitted: 7/16/2010 4:36:01 AM : Outperform Start Price: $14.74 NXTM Score: -94.98

The advent of home dialysis represents a significant improvement in medical effectiveness as well as quality of life. This company makes the devices that allow this to occur. They are at an early stage, having barely scratched the surface of the potential market. With kidney failure on the rise along with the aging population the prospect of rapid growth for a number of years makes this an attractive investment

Recs

0
Member Avatar AmericanGenius (21.97) Submitted: 6/4/2010 11:14:26 AM : Outperform Start Price: $13.85 NXTM Score: -90.09

A rule breaking work horse. Increases customer convinience while decreaseing costs. As health care institutions become more responsible for health care costs (Obama refort) the need for NXTM will only increase. They are on the eve of profitability, and I don't want to miss out.

Recs

0
Member Avatar egipr1 (< 20) Submitted: 2/25/2010 12:01:01 PM : Outperform Start Price: $9.33 NXTM Score: -43.04

yes

Recs

2
Member Avatar HelpU2Build (53.50) Submitted: 2/16/2010 5:16:52 PM : Outperform Start Price: $8.40 NXTM Score: -25.83

Outstanding product potential for reducing medical cost and increasing quality of life results.

Recs

0
Member Avatar stklade (< 20) Submitted: 1/25/2010 1:05:55 PM : Outperform Start Price: $8.01 NXTM Score: -18.66

regular dialysis is very time consuming and person is tie down for lenght of treatment

Recs

0
Member Avatar mas113m (< 20) Submitted: 1/19/2010 12:08:12 PM : Outperform Start Price: $8.88 NXTM Score: -27.35

Home based treatment will be the new standard of care in this field. Higher quality of life while reducing costs. Hopefully profitable this year.

Recs

0
Member Avatar TomFoolNC (29.58) Submitted: 12/16/2009 12:21:40 PM : Outperform Start Price: $7.47 NXTM Score: -4.34

Intl sales, rising GMs, profitable within a year

Recs

0
Member Avatar dgu004 (96.08) Submitted: 12/16/2009 6:44:48 AM : Outperform Start Price: $7.24 NXTM Score: +1.69

Breakthrough in the market with excellent long term growth potential.

Recs

1
Member Avatar hamevorah (< 20) Submitted: 7/13/2009 3:37:18 AM : Outperform Start Price: $4.55 NXTM Score: +58.97

1. Increasing proof of quality of life improvement for home Hemo Dialysis
2. Administration favorable to increasing personalized care (and appropriate reimbursements)

Results 1 - 20 of 30 : 1 2 Next »

Featured Broker Partners


Advertisement